1. Home
  2. OPK vs BZH Comparison

OPK vs BZH Comparison

Compare OPK & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • BZH
  • Stock Information
  • Founded
  • OPK 2007
  • BZH 1985
  • Country
  • OPK United States
  • BZH United States
  • Employees
  • OPK N/A
  • BZH N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • BZH Homebuilding
  • Sector
  • OPK Health Care
  • BZH Consumer Discretionary
  • Exchange
  • OPK Nasdaq
  • BZH Nasdaq
  • Market Cap
  • OPK 1.0B
  • BZH 780.6M
  • IPO Year
  • OPK 1995
  • BZH 1994
  • Fundamental
  • Price
  • OPK $1.38
  • BZH $26.28
  • Analyst Decision
  • OPK Buy
  • BZH Strong Buy
  • Analyst Count
  • OPK 4
  • BZH 3
  • Target Price
  • OPK $2.75
  • BZH $32.00
  • AVG Volume (30 Days)
  • OPK 1.9M
  • BZH 378.5K
  • Earning Date
  • OPK 11-06-2025
  • BZH 11-12-2025
  • Dividend Yield
  • OPK N/A
  • BZH N/A
  • EPS Growth
  • OPK N/A
  • BZH N/A
  • EPS
  • OPK N/A
  • BZH 2.23
  • Revenue
  • OPK $664,029,000.00
  • BZH $2,385,816,000.00
  • Revenue This Year
  • OPK N/A
  • BZH N/A
  • Revenue Next Year
  • OPK $0.84
  • BZH $6.03
  • P/E Ratio
  • OPK N/A
  • BZH $11.76
  • Revenue Growth
  • OPK N/A
  • BZH 9.97
  • 52 Week Low
  • OPK $1.11
  • BZH $17.37
  • 52 Week High
  • OPK $2.04
  • BZH $38.22
  • Technical
  • Relative Strength Index (RSI)
  • OPK 50.29
  • BZH 59.17
  • Support Level
  • OPK $1.34
  • BZH $25.00
  • Resistance Level
  • OPK $1.44
  • BZH $26.31
  • Average True Range (ATR)
  • OPK 0.04
  • BZH 0.71
  • MACD
  • OPK -0.00
  • BZH 0.02
  • Stochastic Oscillator
  • OPK 40.00
  • BZH 69.57

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: